You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abemaciclib

Showing 176 - 198 of 198
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Abemaciclib, LY3023414, Gemcitabine)

Completed
Has Results
  • Pancreatic Ductal Adenocarcinoma
  • Abemaciclib
  • +3 more
  • New Haven, Connecticut
  • +31 more
Nov 6, 2019

Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)

Recruiting
  • Breast Cancer
  • Prato, Please Select:, Italy
    Hospital of Prato
Jul 27, 2022

2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2-

Recruiting
  • Advanced Breast Cancer
  • +2 more
    • Ancona, Italy
    • +28 more
    Jul 27, 2022

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +125 more
    Nov 21, 2022

    Breast Cancer Trial in Tianjin (Dalpiciclib, Pyrotinib, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • Tianjin, China
      Tianjin Cancer Hospital
    Mar 28, 2023

    Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

    Recruiting
    • Triple Negative Breast Cancer
    • +5 more
    • Manchester, Greater Manchester, United Kingdom
    • +6 more
    Jan 5, 2023

    Prostatic Tumors, Castration-Resistant, Drug Therapy, Combination Trial in Chengdu (TQB3616 Capsules Combined With Abiraterone

    Not yet recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • Drug Therapy, Combination
    • TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
    • Chengdu, Sichuan, China
      West China Hospital
    Dec 12, 2021

    Breast Cancer Trial in Singapore (Lenvatinib + Letrozole, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • Singapore, Singapore
      Nationa University Hospital
    Jan 4, 2022

    Healthy Volunteers Trial in Dallas (LY2835219)

    Completed
    Has Results
    • Healthy Volunteers
    • Dallas, Texas
      For additional information regarding investigative sites for thi
    Dec 13, 2018

    Metastatic Breast Cancer Trial in Worldwide (Abemaciclib, Nonsteroidal Aromatase Inhibitor (NSAI))

    Withdrawn
    • Metastatic Breast Cancer
    • Abemaciclib
    • Nonsteroidal Aromatase Inhibitor (NSAI)
    • Daphne, Alabama
    • +118 more
    Sep 4, 2019

    Cancer Target Therapy Efficacy

    Active, not recruiting
    • Cancer
    • RNA sequencing
    • +5 more
    • Walnut, California
    • +6 more
    Sep 13, 2021

    Healthy Volunteers Trial in Madison ([^14C]-LY2835219)

    Completed
    Has Results
    • Healthy Volunteers
    • Madison, Wisconsin
      For additional information regarding investigative sites for thi
    Dec 13, 2018

    Healthy Volunteers Trial in Dallas (LY2835219, Rifampin)

    Completed
    Has Results
    • Healthy Volunteers
    • Dallas, Texas
      For additional information regarding investigative sites for thi
    Dec 13, 2018

    Breast Cancer Trial (Tucidinostat, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Aug 7, 2021

    Breast Cancer Metastatic, Hormone Receptor Positive Malignant Tumor of Breast Trial in Spain (Combination, Rogaratinib +

    Recruiting
    • Breast Cancer Metastatic
    • Hormone Receptor Positive Malignant Neoplasm of Breast
    • Combination, Rogaratinib + palbociclib + fulvestrant
    • Hospitalet de Llobregat, Barcelona, Spain
    • +7 more
    Feb 8, 2022

    Breast Cancer Trial in Singapore (QPOP)

    Recruiting
    • Breast Cancer
    • QPOP
    • Singapore, Singapore
      National University Hospital Singapore
    Feb 9, 2022

    Metastatic Breast Cancer, ER Positive Breast Cancer, HER2-negative Breast Cancer Trial in Prato (Thymidine kinase activity)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Thymidine kinase activity
    • Prato, Tuscany, Italy
      Hospital Santo Stefano
    Dec 10, 2020

    Breast Cancer Trial in Villejuif (Abemaciclib)

    Completed
    • Breast Cancer
    • Abemaciclib
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Mar 27, 2018

    Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Fulvestrant plus AI plus ribociclib
    • AI plus ribociclib
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Apr 16, 2023

    Advanced Cancer, Colorectal Cancer, Mantle Cell Lymphoma Trial in France, United Kingdom, United States (Ramucirumab,

    Completed
    • Advanced Cancer
    • +2 more
    • Birmingham, Alabama
    • +4 more
    Mar 2, 2019

    Breast Cancer Trial in Guangzhou (Fulvestrant combined with Pyrotinib, Capecitabine combined with Pyrotinib)

    Recruiting
    • Breast Cancer
    • Fulvestrant combined with Pyrotinib
    • Capecitabine combined with Pyrotinib
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Nov 23, 2020

    HNSCC, Head and Neck Tumors Trial in Seoul (Abemaciclib)

    Unknown status
    • HNSCC
    • Head and Neck Neoplasms
    • Abemaciclib
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Nov 24, 2017

    Metastatic Breast Cancer Trial in United States (Abemaciclib)

    Approved for marketing
    • Metastatic Breast Cancer
    • Abemaciclib
    • Monterey, California
    • +9 more
    Oct 27, 2017